Lombard Odier Asset Management (Switzerland)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $1.34M | Buy |
|
|||||
|
2022
Q4 | $1.06M | Buy |
|
|||||
|
2022
Q3 | $597K | Sell |
|
|||||
|
2022
Q2 | $797K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $631K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $648K | Sell |
|
|||||
|
2021
Q1 | $612K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $1.64M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $1.28M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $408K | Hold |
|
|||||
|
2019
Q1 | $536K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $142K | Hold |
|
|||||
|
2015
Q4 | $216K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $200K | Sell |
|
|||||
|
2015
Q1 | $276K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $19.1M | Buy |
|
|||||
|
2014
Q2 | $262K | Buy |
|